4 lessons learned from conducting virtual trials: A sit-down with Iqvia

By Melissa Fassbender contact

- Last updated on GMT

Related tags: IQVIA, Virtual clinical trials, Remote clinical trials, Decentralized trials, Contract research, Wearables, Protocol development

It’s a lot more complicated than a simple technology – says Iqvia global head of virtual trials, who shares four lessons learned during a discussion at the company’s headquarters in Research Triangle Park.

Josh Rose is the Vice President of Clinical Development Strategy and Innovation, and the Global Head Virtual Trial Operations at Iqvia.

To discuss the company’s lessons learned from conducting virtual trials, Outsourcing-Pharma went to the source and sat down with Rose at Iqvia’s headquarters in Durham, NC.

Speaking to the complexity of running a trial with this model, Rose said “being cutting edge is not enough.” ​It’s important to start early, “embed virtual thinking into your protocol,” ​he added, addressing four key areas to keep in mind.

For the full discussion, watch the video above.

Related news

Show more

Related products

show more

Local Lab Data Management

Local Lab Data Management

Q2 Solutions | 01-Jul-2020 | Technical / White Paper

When a clinical trial requires local or point-of-care laboratory testing, managing the resulting data can be a significant burden to both the sponsor and...

Laboratory Solutions for COVID-19 Clinical Trials

Laboratory Solutions for COVID-19 Clinical Trials

Q2 Solutions | 10-Jun-2020 | Clinical Study

As a leading laboratory services organization for trials across the globe, we are proud to partner with clients to support COVID-19 clinical trials. Our...

Parents as Gatekeepers for Children with Cancer

Parents as Gatekeepers for Children with Cancer

PRA Health Sciences | 08-Jun-2020 | Technical / White Paper

The RACE for Children Act will require new drugs intended for adult cancer treatment to also be studied in pediatric cancers when the molecular target...

RACE Act Prompts Pediatric Oncology Trials

RACE Act Prompts Pediatric Oncology Trials

PRA Health Sciences | 04-May-2020 | Technical / White Paper

Many providers prescribe drugs off-label to pediatric patients, even though there have been few pediatric trials for many of these drugs. In response,...

Related suppliers

Follow us

Products

View more

Webinars